SSC4D Rabbit Polyclonal Antibody for WB and ELISA - Q8WTU2

Core Product Specifications and Parameters

Biological Background: SSC4D Function and Localization

• SSC4D (Scavenger receptor cysteine-rich domain-containing group B protein) is a secreted protein encoded by the SSC4D gene (also known as SRCRB4D) in humans.
• The protein belongs to the scavenger receptor cysteine-rich (SRCR) superfamily and contains four SRCR domains, as indicated by alternative name "Four scavenger receptor cysteine-rich domains-containing protein".
• Subcellularly, it is secreted and predicted to contain a signal peptide.
• The protein features conserved SRCR repeats with intramolecular disulfide bonds that maintain domain structure.
• Alternative splicing leads to multiple isoforms, adding to functional diversity.
• SSC4D has been identified in proteomics studies, suggesting its presence in various biological contexts.

Experimental Guidance and Technical Tips

• The immunogen covers the C-terminal region (aa 446-575) of human SSC4D, which may contribute to cross-reactivity with mouse and rat orthologs; consider sequence alignment for species-specific applications.
• For Western blot, use the predicted molecular weight of 61 kDa as a reference, but note that alternative splicing or post-translational modifications could yield multiple bands; validate in the relevant sample system.
• For ELISA, the antibody can be explored as a capture or detection reagent; appropriate pairing and optimization are recommended.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio connects diagnostic manufacturers and research labs with a comprehensive portfolio of IVD raw materials, including validated antibodies, bulk ancillary reagents, and rare target sourcing—all from a single partner. For SSC4D research, we supply this polyclonal antibody alongside matching antigens and technical support to accelerate your immunoassay development. Whether you need scalable antibody supplies or custom sourcing for challenging targets, our one-stop model simplifies the path from concept to clinic.